M. Hide, H.-S. Park, A. Igarashi, Y.-M. Ye, T.-B. Kim, and A. Yagami, “Efficacy and Safety of Omalizumab in Japanese and Korean Patients with Chronic Idopathic/Spontaneous Urticaria (CIU/CSU: Results from the Phase 3 POLARIS Study”, J of Skin, vol. 1, no. 3.1, p. s126, Oct. 2017.